Virtual Care Solutions Model to be marketed in Caribbean
VANCOUVER, British Columbia, September 15, 2023 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTC: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is pleased to announce that it has entered into a joint agreement (the “Agreement”) with EGS Health Inc. (“EGS” or the “Partner”) for the purposes of co-marketing and service activities for current and future collaborations.
UniDoc CEO Antonio Baldassarre notes, “UniDoc is excited to take this next step with our Partner. We are seeing an increasing interest in our remote healthcare solutions from medical providers all over the globe. I am looking forward to getting our first equipment order from EGS and, ultimately, to providing accessible health care to patients from across the Caribbean.”
Pursuant to the Agreement, UniDoc has agreed to a strategic marketing and services agreement for the leasing of certain telehealth equipment and the licensing of related software including the Virtual Care Solutions Model (“VCSM”) kiosks from the Company to EGS for monthly service fees. The VCSM is a proprietary customizable and comprehensive telehealth solution that is currently being developed by the Company and is being designed to integrate a range of physical products, web-based services, and analytical tools.
Exclusive territory covered by this agreement includes the Caribbean Countries with the exclusion of: Cuba, Puerto Rico, and Suriname. To maintain exclusivity, EGS must meet certain to be negotiated annual sales targets. The agreement was signed on September 1, 2023, and is valid for a term of 36 months, with options for extension.
UniDoc also agreed to provide certain data management and telecommunications services to be used by the Partner to provide in-suite telehealth and related services in its designated facilities. The software and telecommunications services will provide the Partner with access to an authentication service and on-line portal which permits secure, live-streaming videoconferencing and transmission of diagnostic data between on-site patients physically using individual kiosks units and remote healthcare professionals accessing the portal. Medical personnel for the VCSM kiosks will be coordinated by the Partner.
Additionally, the Company has renewed its previously announced engagement with Clarkham Capital Ltd. (“Clarkham”) (Principal: Sebastian Korbach; address: Flat 285 – 61 Praed St., W2 1NS London, United Kingdom; phone: +44 20 38839398) to provide an investor engagement campaign in Germany.
Clarkham will, as appropriate, prepare articles and coverage on financial platforms and newsletters in Germany, and optionally assist with the translation and distribution of press releases in Germany, in consideration for the payment of €100,000. The promotional activity is expected to occur over a three-month period beginning in late September 2023. Clarkham is an arm’s length party to the Company, and its compensation does not include any options to purchase securities of the Company.
On Behalf of the Board of Directors,
CEO, President & Director
UniDoc Health Corp.
About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTC: UDOCF)
UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician’s office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company’s belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.
For further information, please contact:
UniDoc Investor Relations
Tel: +1 778.383.6731
Matt Chatterton, Director
Tel: +1 778.613.2082
Media Inquiries email@example.com
This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “will be”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the potential to receive purchase orders from EGS, the Company providing accessible healthcare to patients across the Caribbean, the services to be provided by the Company and EGS pursuant to the Agreement, and the services to be provided by Clarkham and the timing thereof.
Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company’s ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company’s annual management discussion and analysis dated July 29, 2022 under the heading “Risks Factors.” Accordingly, readers should not place undue reliance on any such forward-looking information.
Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.